Trial Number

303-22

Condition

Cystic Fibrosis

Participant Age Range

6 years and older

Participant Gender

Any

Enrolling Participants

Yes

Overview

Standardizing Treatments for Pulmonary Exacerbations: A platform for evaluating treatment decisions to improve outcomes (STOP360)

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study.

Provider

Name
Address
Enter Trial number from the area just below the marquee.
How would you prefer to be contacted?
How did you hear about us?
Are you a current Miller Children's patient?
This registration is for:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.